US Patent 11364310 Recombinant virus replicon systems and uses thereof
Patent 11364310 was granted and assigned to Janssen Pharmaceuticals on June, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11364310 Recombinant virus replicon systems and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.